A mathematical model for predicting the adult height of girls with idiopathic central precocious puberty: A European validation

PLoS One. 2018 Oct 9;13(10):e0205318. doi: 10.1371/journal.pone.0205318. eCollection 2018.

Abstract

Background: A previous single-center study established a mathematical model for predicting the adult height (AH) in girls with idiopathic central precocious puberty (CPP).

Objective: To perform internal and external validations by comparing the actual AH to the calculated AH established by this model and to update it.

Methods: The original formula, calculated AH (cm) = 2.21 (height at initial evaluation, SD) + 2.32 (target height, SD) - 1.83 (luteinizing hormone/follicle-stimulating hormone peaks ratio) + 159.68, was established in a sample of 134 girls (group 4) and was applied to additional girls with CPP seen in the same center (group 1, n = 35), in Germany (group 2, n = 43) and in the Netherlands (group 3, n = 72). This formula has been updated based on these extended data, and both versions are available at the following location: http://www.kamick.org/lemaire/med/girls-cpp15.html.

Results: Despite the differences among the 4 groups in terms of their characteristics at the initial evaluation and the percentages of patients treated with the gonadotropin-releasing hormone analogue, they have similar calculated and actual AHs. The actual AHs are 162.2±7.0, 163.0±7.6, 162.4±7.7 and 162.1±5.6 cm in groups 1 to 4, respectively. They are highly correlated with the AHs calculated by the formula established in the original group (group 4), with R at 0.84, 0.67 and 0.69 in groups 1 to 3, respectively. When the actual AHs and the AHs predicted by the Bayley and Pinneau method are compared, the R is 0.76, 0.51 and 0.64 in groups 1 to 3, respectively. The absolute differences between actual AHs and the calculated AHs are greater than 1 SD (5.6 cm) in 15%, 35% and 28% of the patients in groups 1 to 3, respectively.

Conclusion: This study validates and updates the previously established formula for predicting AH in girls with CPP. This updated formula can help clinicians to make treatment decisions.

MeSH terms

  • Adult
  • Body Height / physiology*
  • Child
  • Female
  • Follicle Stimulating Hormone / blood
  • Germany / epidemiology
  • Gonadotropin-Releasing Hormone / blood
  • Humans
  • Luteinizing Hormone / blood
  • Models, Theoretical*
  • Netherlands / epidemiology
  • Puberty, Precocious / blood
  • Puberty, Precocious / epidemiology*
  • Puberty, Precocious / physiopathology*

Substances

  • Gonadotropin-Releasing Hormone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone

Grants and funding

The authors received no specific funding for this work.